Inhibition of ADAM17 attenuates high glucose-induced angiogenesis and inflammation in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression: implications in peritoneal dialysis
Clinical and Experimental Nephrology · 2024
DOI: 10.1007/s10157-024-02546-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, 2024. Verfasst von Na Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and …. Hauptthemen laut MEDLINE: Receptors, Interleukin-8B, ADAM17 Protein, Glucose, Human Umbilical Vein Endothelial Cells. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanghai Municipality, National Natural Science Foundation of China, Research Innovation and Cultivation project of Baoshan site of Renji Hospital.
Abstract (Originalsprache)
Background
Angiogenesis and inflammation are key events leading to peritoneal morphologic alteration and ultrafiltration failure in patients undergoing peritoneal dialysis (PD). The current study aims to explore the role of ADAM17 in the angiogenetic and inflammatory responses of endothelial cells.
Methods
Human umbilical vein endothelial cells (HUVECs) were cultured and treated with a high glucose-containing medium. In parallel experiments, the expression of ADAM17 in HUVECs was inhibited by SiRNA interference. The mRNA and protein expression of ADAM17, GRO-α and CXCR2 were assessed by qPCR and Western blotting, respectively. The concentrations of GRO-α, VEGF, IL-6 and TNF-α in the cellular supernatants were determined by ELISA. Tube formation and migration of HUVECs were evaluated by Matrigel and transwell migration apparatus.
Results
High glucose increased the expression of ADAM17, CXCR2 and GRO-α in cultured HUVECs. RNA silencing of ADAM17 abolished high glucose-mediated increase of GRO-α and CXCR2, which were accompanied by reduced secretion of VEGF, IL-6, TNF-α, as well as tube formation and cell migration in HUVECs.
Conclusions
Inhibition of ADAM17 ameliorates high glucose-induced angiogenic and inflammatory responses in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Sh…
- Department of Nephrology, Baoshan Site of Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 1195877199@qq.com.
- Department of Nephrology, Baoshan Site of Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. yuanjiangzi@aliyun.com.
Förderung
- Natural Science Foundation of Shanghai Municipality
- National Natural Science Foundation of China
- Research Innovation and Cultivation project of Baoshan site of Renji Hospital
Zitieren
APA
Jiang, N., Feng, H., Xie, W., Gu, L., Fang, W., Ding, T., & Yuan, J. (2024). Inhibition of ADAM17 attenuates high glucose-induced angiogenesis and inflammation in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression: implications in peritoneal dialysis. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02546-y
Vancouver
Jiang N, Feng H, Xie W, Gu L, Fang W, Ding T, et al. Inhibition of ADAM17 attenuates high glucose-induced angiogenesis and inflammation in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression: implications in peritoneal dialysis. Clinical and Experimental Nephrology. 2024. doi:10.1007/s10157-024-02546-y
BibTeX
@article{Jiang2024,
author = {Jiang, Na and Feng, Hao and Xie, Weizhen and Gu, Leyi and Fang, Wei and Ding, Tingting and Yuan, Jiangzi},
title = {Inhibition of ADAM17 attenuates high glucose-induced angiogenesis and inflammation in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression: implications in peritoneal dialysis},
journal = {Clinical and Experimental Nephrology},
year = {2024},
doi = {10.1007/s10157-024-02546-y}
}
EUVIMED